Helmar C Lehmann
Overview
Explore the profile of Helmar C Lehmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
2079
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schulten T, Meyer A, Krug U, Lehmann H
Neurol Res Pract
. 2024 Sep;
6(1):45.
PMID: 39300494
Guillain-Barré syndrome is the most common acute inflammatory demyelinating peripheral nerve condition. Occasionally, other autoimmune conditions can mimic Guillain-Barré syndrome but may require different diagnostic workup and treatment. We report...
2.
Kohle F, Stark C, Klunter H, Wernicke D, Wunderlich G, Fink G, et al.
J Peripher Nerv Syst
. 2024 Sep;
29(4):453-463.
PMID: 39219364
Background/aims: Peripheral neuropathies perturbate the sensorimotor system, causing difficulties in walking-related motor tasks and, eventually, falls. Falls result in functional dependency and reliance on healthcare, especially in older persons. We...
3.
Svacina M, Sprenger-Svacina A, Kohle F, Wunderlich G, Lehmann H, Schneider C
Muscle Nerve
. 2024 Aug;
70(5):954-962.
PMID: 39136612
Introduction/aims: Myotonia is a key symptom of myotonic dystrophies (DM), and its quantification is challenging. This exploratory study evaluated the utility of tissue Doppler ultrasound (TDU) to assess myotonia in...
4.
Kaulen B, Hagemann L, Lehmann H
Fortschr Neurol Psychiatr
. 2024 Jul;
92(6):e1.
PMID: 38986498
No abstract available.
5.
Streckmann F, Elter T, Lehmann H, Baurecht H, Nazarenus T, Oschwald V, et al.
JAMA Intern Med
. 2024 Jul;
184(9):1046-1053.
PMID: 38949824
Importance: Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and clinically relevant adverse effect of chemotherapy, negatively impacting patient quality of life. The lack of effective preventive or therapeutic options...
6.
Kaulen B, Hagemann L, Lehmann H
Fortschr Neurol Psychiatr
. 2024 Jun;
92(6):247-258.
PMID: 38876143
Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic autoimmune disease of the peripheral nervous system. It is often difficult to diagnose, but severaly therapeutic options are nowadays available...
7.
Sprenger-Svacina A, Klein I, Svacina M, Bobylev I, Kohle F, Schneider C, et al.
J Neuroimmune Pharmacol
. 2024 May;
19(1):26.
PMID: 38819756
The composition of gut microbiota plays a pivotal role in priming the immune system and thus impacts autoimmune diseases. Data on the effects of gut bacteria eradication via systemic antibiotics...
8.
Zaninello M, Schlegel T, Nolte H, Pirzada M, Savino E, Barth E, et al.
Sci Adv
. 2024 May;
10(22):eadn2050.
PMID: 38809982
Transporting and translating mRNAs in axons is crucial for neuronal viability. Local synthesis of nuclear-encoded mitochondrial proteins protects long-lived axonal mitochondria from damage; however, the regulatory factors involved are largely...
9.
Kohle F, Wunderlich G, Fink G, Schroeter M, Lehmann H, Schneider C
J Neurol
. 2024 Apr;
271(7):4406-4411.
PMID: 38656623
Objectives: This case series reports clinical features and outcome of four patients with non-systemic vasculitic neuropathy (NSVN) treated with the anti-CD20 agent rituximab. Methods: Clinical, electrophysiological and biopsy data were...
10.
GuNTHER R, Wurster C, Brakemeier S, Osmanovic A, Schreiber-Katz O, Petri S, et al.
Lancet Reg Health Eur
. 2024 Feb;
39:100862.
PMID: 38361750
Background: Evidence for the efficacy of nusinersen in adults with 5q-associated spinal muscular atrophy (SMA) has been demonstrated up to a period of 16 months in relatively large cohorts but...